美国FDA药品数据库-药物在线

商品名	申请号	产品号	申请类型	活性成分	剂型/给药途径	规格/剂量	RLD	RS	申请号原始批准/暂定批准日期	产品号批准日期	申请人	市场状态
LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE	022061	001	NDA	LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE	TABLET; ORAL	150MG; 200MG; 300MG	No	No	2008/10/21 (TA)	--	MATRIX LABS	None (Tentative Approval)
LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE	022464	001	NDA	LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE	TABLET; ORAL	150MG; 200MG; 300MG	No	No	2009/12/22 (TA)	--	STRIDES ARCOLAB LTD	None (Tentative Approval)
LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE	202157	001	NDA	LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE	TABLET; ORAL	150MG; 200MG; 300MG	No	No	2011/11/18 (TA)	--	HETERO LABS UNIT III	None (Tentative Approval)
LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE	202589	001	NDA	LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE	TABLET; ORAL	150MG; 200MG; 300MG	No	No	2012/02/08 (TA)	--	MACLEODS PHARMS LTD	None (Tentative Approval)
LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE	202685	001	NDA	LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE	TABLET, FOR SUSPENSION; ORAL	30MG; 50MG; 60MG	No	No	2012/09/21 (TA)	--	STRIDES ARCOLAB LTD	None (Tentative Approval)
LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE	203076	001	NDA	LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE	TABLET; ORAL SUSPENSION	30MG; 50MG; 60MG	No	No	2012/10/16 (TA)	--	CIPLA LTD	None (Tentative Approval)